I25 I35 I34 I71
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients for planned heart surgery (e.g. coronary bypass surgery or valve surgery) with preoperative anticoagulation (therapy with apixaban / rivaroxaban / edoxaban or ticagrelor / clopidogrel / prasugrel with / without ASA with / without bridging LMWH / unfractionated heparin)
Exclusion criteria
Exclusion criteria: 1. Rejection of the study 2. Patients with caregiver
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a. Blood loss intraoperatively after switching off the HLM (blood volume in cell saver [CS] after centrifugation) b. Postoperative cardiac tamponade (re-sternotomy) c. Drainage flow rate, use CS postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| d. Postoperative ventilation duration e. ICU length of stay f. Hospital Length of Stay | — |
Countries
Germany
Contacts
Universitätsklinikum Regensburg, Klinik und Poliklinik für Herz-, Thorax- und herznahe Gefäßchirurgie